Literature DB >> 27657335

Dengue Protease Substrate Recognition: Binding of the Prime Side.

Kuan-Hung Lin1, Ellen A Nalivaika1, Kristina L Prachanronarong1, Nese Kurt Yilmaz1, Celia A Schiffer1.   

Abstract

Dengue virus (DENV), transmitted predominantly in tropical and subtropical regions by the mosquito Aedes aegypti, infects millions of people and leads to dengue fever and thousands of deaths each year. There are no direct-acting antivirals to combat DENV, and molecular and structural knowledge is required to develop such compounds. The dengue NS2B/NS3 protease is a promising target for direct-acting antivirals, as viral polyprotein cleavage during replication is required for the maturation of the viral particle. The NS2B/NS3 protease processes 8 of the 13 viral polyprotein cleavage sites to allow viral maturation. Although these sites share little sequence homology beyond the P1 and P2 positions, most are well conserved among the serotypes. How the other substrate residues, especially at the P' side, affect substrate recognition remains unclear. We exploited the tight-binding general serine protease inhibitor aprotinin to investigate protease-substrate interactions at the molecular level. We engineered aprotinin's binding loop with sequences mimicking the P' side of DENV substrates. P' residues significantly modulate substrate affinity to protease, with inhibition constants varying from nanomolar to sub-millimolar. Structural and dynamic analysis revealed the molecular basis of this modulation and allowed identifying optimal residues for each of the P' positions. In addition, isothermal titration calorimetry showed binding to be solely entropy driven for all constructs. Potential flaviviral P' side inhibitors could benefit from mimicking the optimal residues at P' positions and incorporate hydrophobicity and rigidity to maintain entropic advantage for potency.

Entities:  

Keywords:  dengue; peptide sequence; protease inhibitor; substrate recognition; viral protease

Mesh:

Substances:

Year:  2016        PMID: 27657335      PMCID: PMC5221572          DOI: 10.1021/acsinfecdis.6b00131

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  36 in total

1.  Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field.

Authors:  Devleena Shivakumar; Joshua Williams; Yujie Wu; Wolfgang Damm; John Shelley; Woody Sherman
Journal:  J Chem Theory Comput       Date:  2010-04-14       Impact factor: 6.006

2.  Competitive inhibition of the dengue virus NS3 serine protease by synthetic peptides representing polyprotein cleavage sites.

Authors:  Santad Chanprapaph; Patchreenart Saparpakorn; Chak Sangma; Pornwaratt Niyomrattanakit; Supa Hannongbua; Chanan Angsuthanasombat; Gerd Katzenmeier
Journal:  Biochem Biophys Res Commun       Date:  2005-05-20       Impact factor: 3.575

3.  Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries.

Authors:  Jun Li; Siew Pheng Lim; David Beer; Viral Patel; Daying Wen; Christine Tumanut; David C Tully; Jennifer A Williams; Jan Jiricek; John P Priestle; Jennifer L Harris; Subhash G Vasudevan
Journal:  J Biol Chem       Date:  2005-06-01       Impact factor: 5.157

Review 4.  Immunopathological mechanisms in dengue and dengue hemorrhagic fever.

Authors:  Sharone Green; Alan Rothman
Journal:  Curr Opin Infect Dis       Date:  2006-10       Impact factor: 4.915

5.  Structural basis and distal effects of Gag substrate coevolution in drug resistance to HIV-1 protease.

Authors:  Ayşegül Özen; Kuan-Hung Lin; Nese Kurt Yilmaz; Celia A Schiffer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-29       Impact factor: 11.205

6.  Nonlinear regression models for determination of nicotinamide adenine dinucleotide content in human embryonic stem cells.

Authors:  Anton Salykin; Petr Kuzmic; Olga Kyrylenko; Jindra Musilova; Zdenek Glatz; Petr Dvorak; Sergiy Kyrylenko
Journal:  Stem Cell Rev Rep       Date:  2013-12       Impact factor: 5.739

7.  Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold.

Authors:  Alexander E Aleshin; Sergey A Shiryaev; Alex Y Strongin; Robert C Liddington
Journal:  Protein Sci       Date:  2007-03-30       Impact factor: 6.725

8.  SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells.

Authors:  B A Malcolm; R Liu; F Lahser; S Agrawal; B Belanger; N Butkiewicz; R Chase; F Gheyas; A Hart; D Hesk; P Ingravallo; C Jiang; R Kong; J Lu; J Pichardo; A Prongay; A Skelton; X Tong; S Venkatraman; E Xia; V Girijavallabhan; F G Njoroge
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

Review 9.  Dengue: the risk to developed and developing countries.

Authors:  T P Monath
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

10.  NMR analysis of a novel enzymatically active unlinked dengue NS2B-NS3 protease complex.

Authors:  Young Mee Kim; Shovanlal Gayen; CongBao Kang; Joma Joy; Qiwei Huang; Angela Shuyi Chen; John Liang Kuan Wee; Melgious Jin Yan Ang; Huichang Annie Lim; Alvin W Hung; Rong Li; Christian G Noble; Le Tian Lee; Andy Yip; Qing-Yin Wang; Cheng San Brian Chia; Jeffrey Hill; Pei-Yong Shi; Thomas H Keller
Journal:  J Biol Chem       Date:  2013-03-19       Impact factor: 5.157

View more
  6 in total

1.  Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.

Authors:  Kuan-Hung Lin; Akbar Ali; Linah Rusere; Djade I Soumana; Nese Kurt Yilmaz; Celia A Schiffer
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

2.  Platform to Discover Protease-Activated Antibiotics and Application to Siderophore-Antibiotic Conjugates.

Authors:  Jonathan H Boyce; Bobo Dang; Beatrice Ary; Quinn Edmondson; Charles S Craik; William F DeGrado; Ian B Seiple
Journal:  J Am Chem Soc       Date:  2020-12-10       Impact factor: 15.419

Review 3.  Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond.

Authors:  Ashley N Matthew; Florian Leidner; Gordon J Lockbaum; Mina Henes; Jacqueto Zephyr; Shurong Hou; Desaboini Nageswara Rao; Jennifer Timm; Linah N Rusere; Debra A Ragland; Janet L Paulsen; Kristina Prachanronarong; Djade I Soumana; Ellen A Nalivaika; Nese Kurt Yilmaz; Akbar Ali; Celia A Schiffer
Journal:  Chem Rev       Date:  2021-01-07       Impact factor: 60.622

4.  Flavivirus enzymes and their inhibitors.

Authors:  Ekaterina Knyazhanskaya; Marc C Morais; Kyung H Choi
Journal:  Enzymes       Date:  2021-09-01

5.  Viral proteases: Structure, mechanism and inhibition.

Authors:  Jacqueto Zephyr; Nese Kurt Yilmaz; Celia A Schiffer
Journal:  Enzymes       Date:  2021-11-17

Review 6.  Antiviral Agents against Flavivirus Protease: Prospect and Future Direction.

Authors:  Subodh K Samrat; Jimin Xu; Zhong Li; Jia Zhou; Hongmin Li
Journal:  Pathogens       Date:  2022-02-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.